This guideline covers managing diabetes and its complications in women who are planning pregnancy or are already pregnant. It aims to improve the diagnosis of gestational diabetes and help women with diabetes to self-manage their blood glucose levels before and during pregnancy.
In August 2015, changes were made to recommendations 1.1.17, 1.1.29, 1.1.34 and 1.3.28 for consistency with other NICE guidelines.
This guideline includes recommendations on:
- preconception planning and care
- diagnosing and managing gestational diabetes
- antenatal care
- intrapartum care
- neonatal care
- postnatal care, including ongoing blood glucose testing for women who have had gestational diabetes
Who is it for?
- Healthcare professionals
- Commissioners and providers
- Women with diabetes who are planning a pregnancy or are pregnant and women at risk of, or diagnosed with, gestational diabetes
Guideline development process
This guideline updates and replaces NICE guideline CG63 (March 2008).
Next review date: 2019
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.